共 332 条
[1]
Kanis JA(2013)European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 24 23-57
[2]
McCloskey EV(1998)Treatment of postmenopausal osteoporosis N Engl J Med 338 736-746
[3]
Johansson H(2015)Treatment of primary osteoporosis in men Clin Interv Aging 10 105-115
[4]
Cooper C(2008)Medication compliance and persistence: terminology and definitions Value Health 11 44-47
[5]
Rizzoli R(2006)Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 1013-1022
[6]
Reginster JY(2012)Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA) Osteoporos Int 23 433-443
[7]
Eastell R(2006)Compliance with osteoporosis therapy is the weakest link Lancet 368 973-974
[8]
Giusti A(2011)Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch Osteoporos 6 59-155
[9]
Bianchi G(2011)Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis Osteoporos Int 22 967-982
[10]
Cramer JA(2012)The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis Expert Rev Pharmacoecon Outcomes Res 12 159-166